Yellow Eyes: What Could Be Causing It

Why Eyes Turn Yellow: The Bilirubin Connection

Yellow eyes appear when bilirubin, a yellow pigment produced during normal red blood cell breakdown, accumulates faster than the body can process and excrete it. The sclera (white of the eye) contains elastin fibers with high affinity for bilirubin, which makes the eyes one of the first places yellowing becomes visible. Skin discoloration often follows, but scleral icterus can be detected at lower bilirubin levels.

How Bilirubin Is Produced

Every day, the human body breaks down roughly 1 percent of circulating red blood cells. Hemoglobin released from these cells is converted to unconjugated (indirect) bilirubin, which travels to the liver bound to albumin. The liver conjugates bilirubin with glucuronic acid, making it water-soluble. Conjugated (direct) bilirubin is then excreted into bile and eventually eliminated through stool 1.

Where the System Can Break Down

The problem can originate at any of three stages. Excess production of bilirubin (pre-hepatic), impaired liver processing (hepatic), or blocked excretion into the intestine (post-hepatic). Identifying which stage is responsible is the foundation of every jaundice workup 2.

Normal total bilirubin ranges from 0.1 to 1.2 mg/dL. Scleral icterus typically becomes clinically apparent once levels exceed 2.5 mg/dL, though some physicians can detect it at 2.0 mg/dL in patients with lighter eye pigmentation 3.

Pre-Hepatic Causes: Too Much Bilirubin Being Made

When red blood cells are destroyed faster than normal (hemolysis), the liver receives more unconjugated bilirubin than it can conjugate. Labs in this category show elevated indirect bilirubin with normal or mildly elevated liver enzymes.

Hemolytic Anemias

Autoimmune hemolytic anemia, sickle cell disease, thalassemia, glucose-6-phosphate dehydrogenase (G6PD) deficiency, and hereditary spherocytosis all increase red cell turnover. G6PD deficiency alone affects an estimated 400 million people worldwide, according to WHO data 4. Patients with sickle cell disease experience chronic low-grade hemolysis punctuated by acute crises that can spike bilirubin above 10 mg/dL.

Ineffective Erythropoiesis

Conditions like megaloblastic anemia (from vitamin B12 or folate deficiency) destroy red cell precursors in the bone marrow before they reach circulation. The bilirubin load rises even though peripheral blood cell counts are low. A reticulocyte count helps distinguish this pattern from classic hemolysis 5.

Drug-Induced and Transfusion-Related Hemolysis

Certain medications (dapsone, ribavirin, penicillin at high doses) can trigger hemolysis. Large-volume blood transfusions may also raise bilirubin as transfused cells are cleared. These causes resolve once the offending agent is removed or transfusion frequency is reduced.

Hepatic Causes: The Liver Cannot Keep Up

When the liver itself is damaged or dysfunctional, both conjugated and unconjugated bilirubin may rise. Liver enzymes (ALT, AST) are typically elevated, and the pattern of elevation helps identify the specific disease.

Viral Hepatitis

Hepatitis A, B, C, and E each can cause acute jaundice. Hepatitis A remains the most common cause of acute viral jaundice globally. In the United States, hepatitis C affects approximately 2.4 million people, many of whom remain undiagnosed for years before presenting with jaundice or other signs of advanced liver disease, according to CDC surveillance data 6. A 2023 meta-analysis found that direct-acting antiviral therapy achieves sustained virologic response in over 95 percent of hepatitis C patients 7.

Alcoholic and Metabolic Liver Disease

Alcoholic hepatitis can present with rapid-onset jaundice, fever, and leukocytosis. The Maddrey discriminant function score, calculated from prothrombin time and bilirubin, guides treatment decisions. A score of 32 or higher indicates severe disease with roughly 50 percent 28-day mortality without treatment 8. Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) rarely causes overt jaundice until cirrhosis develops, but affects an estimated 30 percent of the global adult population 9.

Gilbert Syndrome

This genetic variant deserves special mention because it is common and benign. Gilbert syndrome affects 3 to 7 percent of the population and results from reduced activity of the UDP-glucuronosyltransferase enzyme (UGT1A1). Bilirubin rises modestly (usually 1.5 to 3.0 mg/dL) during fasting, illness, or stress. The eyes may appear faintly yellow, especially after poor sleep or skipped meals 10. No treatment is needed.

Drug-Induced Liver Injury

Over 1,000 medications and supplements have been implicated in liver injury. Acetaminophen remains the most common cause of acute liver failure in the United States and United Kingdom. The NIH LiverTox database catalogs all known hepatotoxic drugs 11.

Dr. Naga Chalasani, a hepatologist at Indiana University and co-author of the ACG Clinical Guideline on drug-induced liver injury, has stated: "Any medication, herbal product, or dietary supplement should be considered a potential cause of liver injury in a patient presenting with new jaundice" 12.

Post-Hepatic (Obstructive) Causes: Bile Cannot Drain

When bile flow is physically blocked, conjugated bilirubin backs up into the bloodstream. Labs show elevated direct bilirubin and markedly elevated alkaline phosphatase and gamma-glutamyl transferase (GGT). Urine turns dark (tea-colored), and stools become pale or clay-colored.

Gallstones (Choledocholithiasis)

Gallstones migrating into the common bile duct are the most frequent cause of obstructive jaundice. Roughly 10 to 15 percent of adults in Western countries have gallstones, and about 1 to 4 percent of those individuals develop bile duct obstruction 13. Treatment is endoscopic retrograde cholangiopancreatography (ERCP) for stone removal, typically followed by cholecystectomy.

Pancreatic and Biliary Cancers

Painless progressive jaundice in a patient over 50 raises concern for pancreatic head cancer or cholangiocarcinoma. Pancreatic cancer carries a 5-year survival rate of approximately 12 percent, according to SEER data 14. Early imaging with contrast-enhanced CT or MRI/MRCP is critical for staging.

Strictures and Primary Sclerosing Cholangitis

Bile duct strictures may be benign (post-surgical, chronic pancreatitis) or malignant. Primary sclerosing cholangitis (PSC) causes progressive inflammation and fibrosis of intra- and extra-hepatic bile ducts. PSC is strongly associated with inflammatory bowel disease; up to 70 percent of PSC patients have concurrent ulcerative colitis 15.

How Yellow Eyes Are Diagnosed

The diagnostic approach follows a systematic pattern: history, physical exam, laboratory testing, then imaging as needed. A skilled clinician can often narrow the differential before imaging results return.

Step 1: Laboratory Workup

The initial panel typically includes total and direct bilirubin, ALT, AST, alkaline phosphatase, GGT, albumin, prothrombin time (PT/INR), and a complete blood count with reticulocyte count. The ratio of direct to total bilirubin is one of the most informative results. A direct fraction above 50 percent suggests hepatic or post-hepatic disease. A predominantly indirect pattern points toward hemolysis or Gilbert syndrome 2.

Step 2: Imaging

Right upper quadrant ultrasound is the standard first imaging study. It identifies dilated bile ducts (suggesting obstruction), gallstones, liver masses, and changes in liver texture. Sensitivity for detecting common bile duct stones is approximately 50 to 70 percent, but for duct dilation it exceeds 90 percent 16. CT scan or MRCP follows when ultrasound findings are inconclusive or malignancy is suspected.

Step 3: Specialized Testing

Depending on the clinical picture, additional tests may include hepatitis serologies (A, B, C, E), autoimmune markers (ANA, anti-smooth muscle antibody, IgG levels for autoimmune hepatitis), ceruloplasmin (for Wilson disease in younger patients), and iron studies (for hemochromatosis).

Treatment Depends Entirely on the Cause

There is no single treatment for yellow eyes. Therapy targets the underlying condition driving bilirubin elevation. This is why accurate diagnosis matters more than symptom management.

Treating Pre-Hepatic Jaundice

For hemolytic conditions, treatment addresses the specific cause. Autoimmune hemolytic anemia may respond to corticosteroids or rituximab. G6PD deficiency requires avoidance of oxidative triggers (fava beans, specific medications). Sickle cell management includes hydroxyurea, voxelotor, and transfusion support 17.

Treating Hepatic Jaundice

Viral hepatitis treatment has changed dramatically. Direct-acting antivirals cure hepatitis C in 8 to 12 weeks. Hepatitis B is managed with tenofovir or entecavir for long-term viral suppression. Alcoholic hepatitis requires abstinence; severe cases may receive prednisolone for 28 days based on the STOPAH trial findings 18.

For drug-induced liver injury, the offending agent must be stopped immediately. Acetaminophen overdose is treated with N-acetylcysteine (NAC), which is effective even in cases presenting up to 72 hours after ingestion.

Treating Post-Hepatic Jaundice

Obstructive causes often require procedural intervention. ERCP can remove bile duct stones and place stents to relieve malignant obstruction. Surgical resection (Whipple procedure) may be appropriate for localized pancreatic head tumors. Biliary stenting provides palliation when surgery is not feasible.

The American College of Gastroenterology guideline on gallstone management recommends: "ERCP with sphincterotomy is the preferred therapeutic approach for common bile duct stones" 19.

When Yellow Eyes Are an Emergency

Most causes of yellow eyes develop gradually, but certain presentations require urgent evaluation. Same-day emergency care is appropriate for Charcot triad (fever, jaundice, right upper quadrant pain), which suggests ascending cholangitis. Altered mental status with jaundice may indicate hepatic encephalopathy or acute liver failure.

Red Flags That Require Immediate Medical Attention

A combination of jaundice with fever above 101.3°F and rigors suggests biliary sepsis, which carries mortality rates of 10 to 30 percent without timely intervention 20. Rapid-onset jaundice with coagulopathy (INR above 1.5) and encephalopathy meets the definition of acute liver failure, a condition that may require liver transplant evaluation within 24 to 48 hours.

When It Can Wait

Isolated mild yellowing of the eyes in a young, otherwise healthy patient with normal liver enzymes and mildly elevated indirect bilirubin almost always represents Gilbert syndrome. A primary care visit within one to two weeks is reasonable. Stable chronic jaundice in a patient already under hepatology care does not require emergency evaluation unless new symptoms appear.

Yellow Eyes in Specific Populations

Certain groups face unique risks and diagnostic considerations that alter the standard workup.

Newborns

Physiologic jaundice occurs in approximately 60 percent of term newborns and 80 percent of preterm infants within the first week of life. Bilirubin levels peak around day 3 to 5 and typically resolve by day 14. The American Academy of Pediatrics recommends universal bilirubin screening before hospital discharge, with phototherapy thresholds based on the Bhutani nomogram 21.

Pregnant Women

Jaundice in pregnancy raises concern for intrahepatic cholestasis of pregnancy (ICP), HELLP syndrome, or acute fatty liver of pregnancy (AFLP). ICP affects 0.2 to 2 percent of pregnancies and is managed with ursodeoxycholic acid, though early delivery may be needed after 37 weeks. AFLP is a medical emergency requiring immediate delivery 22.

Older Adults

New jaundice in adults over 60 has a higher pretest probability for malignancy. Painless jaundice with weight loss should prompt cross-sectional imaging before any other workup is completed.

Lifestyle and Supportive Measures

While treating the root cause is essential, certain supportive steps apply across most forms of jaundice.

Avoid alcohol completely until the cause is identified and bilirubin normalizes. Review all medications and supplements with a physician; stop any non-essential agents that are potentially hepatotoxic. Maintain adequate hydration. Do not take extra acetaminophen for unrelated aches while jaundice is being evaluated. Eat regular meals (fasting worsens bilirubin in Gilbert syndrome).

No over-the-counter supplement has proven efficacy for lowering bilirubin in adults. "Liver cleanses" and "detox" products lack clinical evidence and may worsen liver injury 11.